SCHEMBL7436142

SCHEMBL7436142

C/C=C/CCC(N)C(=O)OC

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.41
GRIK2 Q13002 2/20 0.41
ARG2 P78540 1/20 0.38
LTA4H P09960 3/20 0.37
SLC1A1 P43005 1/20 0.35
P2RY10 O00398 1/20 0.34
GPR174 Q9BXC1 1/20 0.34
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
GFPT1 Q06210 1/20 0.31
HDAC2 Q92769 1/20 0.31
ZDHHC7 Q9NXF8 1/20 0.31
TSHR P16473 1/20 0.30
KIF11 P52732 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7436145 1.00 GRIK1 (0.41) GRIK1GRIK2ARG2LTA4HSLC1A1
SCHEMBL7430683 0.89 GRIK1 (0.39) GRIK1GRIK2LTA4HSLC1A1P2RY10
SCHEMBL7430691 0.89 GRIK1 (0.39) GRIK1GRIK2LTA4HSLC1A1P2RY10
SCHEMBL7433486 0.87 P2RY10 (0.40) GRIK1GRIK2LTA4HP2RY10GPR174
SCHEMBL7433487 0.87 P2RY10 (0.40) GRIK1GRIK2LTA4HP2RY10GPR174
SCHEMBL13662314 0.80 P2RY10 (0.36) ARG2LTA4HSLC1A1P2RY10GPR174
SCHEMBL11776470 0.79 SMN1; SMN2 (0.42) LTA4HSLC1A1CA1CA2SMN1; SMN2
SCHEMBL15723449 0.78 ALDH1A1 (0.40) LTA4HCA1CA2SMN1; SMN2TSHR
SCHEMBL7274493 0.78 ALDH1A1 (0.40) LTA4HCA1CA2SMN1; SMN2TSHR
SCHEMBL28363798 0.78 PPARG (0.38) PPARGPPARDPPARACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4973585-A INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME MERRELL DOW PHARMACEUTICALS (US) 1990-11-27 US disclosed
EP-0249223-A2 Novel antihypertensive agent MERRELL DOW PHARMACEUTICALS INC. (US) 1987-12-16 EP disclosed